These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 23936949

  • 1. Prevalence of known prognostic factors in female breast carcinoma including oestrogen receptor, progesterone receptor and Her-2/neu status--a study in a tertiary care centre.
    Chakrabarti S, Karmakar R, Barui G, Maity PK, Bandyopadhyay A, Roy A.
    J Indian Med Assoc; 2012 Dec; 110(12):876-9. PubMed ID: 23936949
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G, Beadle G, Thomas S, Mengersen K, Stein S.
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
    Recăreanu F, Simionescu C, Georgescu CV, Pirici E.
    Rom J Morphol Embryol; 2011 Oct; 52(3 Suppl):1059-64. PubMed ID: 22119825
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The prevalence and significance of oestrogen receptor (ER) positivity in breast cancer at the University Hospital of the West Indies, Jamaica.
    Alfred R, Chin SN, Williams E, Walters C, Barton EN, Shah D.
    West Indian Med J; 2012 Nov; 61(8):795-801. PubMed ID: 23757900
    [Abstract] [Full Text] [Related]

  • 11. Do we need HER-2/neu testing for all patients with primary breast carcinoma?
    Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R.
    Cancer; 2003 Dec 15; 98(12):2547-53. PubMed ID: 14669272
    [Abstract] [Full Text] [Related]

  • 12. Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.
    Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, Berteloot P, Amant F, Vergote I, Christiaens MR.
    J Clin Pathol; 2005 Jun 15; 58(6):611-6. PubMed ID: 15917412
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y, Guan Y, Zhao WH, Li Q, Xu BH.
    Zhonghua Zhong Liu Za Zhi; 2008 Dec 15; 30(12):917-20. PubMed ID: 19173993
    [Abstract] [Full Text] [Related]

  • 15. Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT, Jamal S.
    J Coll Physicians Surg Pak; 2010 Mar 15; 20(3):181-5. PubMed ID: 20392381
    [Abstract] [Full Text] [Related]

  • 16. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.
    Zhonghua Zhong Liu Za Zhi; 2010 Jul 15; 32(7):520-5. PubMed ID: 21029696
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Age related association of Her-2/neu with prognostic markers in female breast carcinoma.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2010 Sep 15; 20(9):590-4. PubMed ID: 20810050
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical characterization of molecular subtypes of invasive breast cancer: a study from North India.
    Verma S, Bal A, Joshi K, Arora S, Singh G.
    APMIS; 2012 Dec 15; 120(12):1008-19. PubMed ID: 23030684
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan.
    Almasri NM, Al Hamad M.
    Breast Cancer Res; 2005 Dec 15; 7(5):R598-604. PubMed ID: 16168103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.